When compared to spleen or lymph node cells, resident peritoneal cavity cells respond poorly to T-cell activation in vitro. The greater proportional representation of macrophages in this cell source has been shown to actively suppress the T-cell response. Peritoneal macrophages exhibit an immature phenotype (MHC class II lo , B7 lo ) that reduces their efficacy as antigen-presenting cells. Furthermore, these cells readily express inducible nitric oxide synthase (iNOS), an enzyme that promotes T-cell tolerance by catabolism of the limiting amino acid arginine. Here, we investigate the ability of exogenous T-cell costimulation to recover the peritoneal T-cell response. We show that CD28 ligation failed to recover the peritoneal T-cell response and actually suppressed responses that had been recovered by inhibiting iNOS. As indicated by cytokine ELISpot and neutralizing monoclonal antibody (mAb) treatment, this 'cosuppression' response was due to CD28 ligation increasing the number of interferon (IFN)-c-secreting cells. Our results illustrate that cellular composition and cytokine milieu influence T-cell costimulation biology.
INTRODUCTION
Collaboration between antigen-presenting cells (APCs) and T lymphocytes is a key checkpoint in the regulation of adaptive immunity. T-cell activation requires that APCs provide two signals: processed (peptide) antigen complexed with the class II major histocompatibility complex (MHC) to engage the T-cell receptor (signal 1) and a costimulatory signal via CD80/86 (B7) engagement of CD28 on the T cell (signal 2). 1, 2 Since the T-cell receptor and CD28 are expressed constitutively by resting/naive T cells appropriate APC expression of class II MHC and B7 molecules is a major checkpoint for controlling T-cell activation. Improper expression of these receptor ligand combinations can promote T-cell anergy or apoptosis. 3 The great majority of costimulation studies are conducted in vitro with low APC/T cell ratios inherent to the natural composition of conventional lymphoid tissue. 4 There has been little investigation of the effect high APC/T cell ratios could have on T-cell activation. This is important to consider because of the paralyzed T-cell function seen in tumor microenvironments enriched with immunosuppressive, myeloid cells. 5 High myeloid/T cell ratios temper T-cell function, both at the end of normal immune responses and in tumors where essential T-cell effector functions have been abrogated. [6] [7] [8] [9] [10] [11] APCs dampen T-cell function by several means, including the expression of enzymes that consume critical amino acids, production of immunoregulatory hormones and cytokines, and generation of regulatory T cells. 7, 9, 12 We have shown that cultures of peritoneal cavity (PerC) cells inherently have high macrophage (Mw) to T cell ratios (Mw/T). 4, 13 Interferon (IFN)-c released by activated T cells triggers the Mws to express indoleamine 2,3-dioxygenase (IDO) and inducible nitric oxide synthase (iNOS), enzymes that inhibit T-cell activation by depleting tryptophan and arginine. [12] [13] [14] With their naturally high Mw/T cell ratios, these cultures mimic an essential feature of tumor microenvironments. This provides a model to assess immunomodulatory strategies for promoting immunity under conditions of myeloid suppression.
In the studies described herein, we determined whether costimulation could increase the PerC T-cell response liberated by inhibiting iNOS. Since PerC Mws have an immature phenotype (MHC class II lo , B7 lo ), we reasoned that CD28 ligation would costimulate T cells in these cultures. 13, 15 In contrast, we found that CD28 ligation suppressed the T-cell proliferative response. This observation is discussed with respect to the consideration of myeloid/lymphoid ratios in experimental design when assessing the efficacy of immunomodulatory drugs.
MATERIALS AND METHODS
Mice Two-to four-month-old male and female mice, bred and maintained at Rider University, were handled in accord with NIH, Animal Welfare Act and Rider University IACUC guidelines. /ml) of cells, in RPMI-1640 culture media (Life Technologies, Grand Island, NY, USA) supplemented with 10% fetal calf serum, 0.1 mM nonessential amino acids, 100 U/ml penicillin, 100 mg/ml streptomycin, 50 mg/ml gentamicin, 2 mM L-glutamine, 2310
25 M 2-ME and 10 mM HEPES, were incubated in a humidified atmosphere of 5% CO 2 at 37uC in 96-well 'U'-, 'V'-or flat-bottom microtiter plates (Corning Costar, Fisher Scientific, Pittsburgh, PA). For anti-CD3 stimulation soluble anti-CD3e monoclonal antibody (mAb) (clone 145-2C11) 16 (eBioscience, San Diego, CA, USA), was added at 1.0 mg/ml. Where exogenous costimulation was tested anti-CD28 (clone 37.51), 17 or an isotype-matched hamster IgG control (eBioscience) was added at 1.0 mg/ml or B7.1-Fc or B7.2-Fc (R&D Systems, Minneapolis, MN, USA) were added at 5.0-10.0 mg/ml. Mitogen (concanavalin A (ConA)) and superantigen (Staphylococcal enterotoxin B (SEB)) (Sigma Chemical, St Louis, MO, USA) were added at 2 and 5 mg/ ml, respectively. Anti-IFN-c mAb (XMG1.2; eBioscience) or anti-IL-10 mAb (JES5-2A5; eBioscience) at 5-10 mg/ml were added at culture initiation. Based on prior studies, to inhibit arginine catabolism in IFN-cRKO mice the arginase (ARG) inhibitor N-w-hydroxy-nor-Larginine (1-NA; CalBiochem, San Diego, CA, USA) was added; to inhibit arginine catabolism in C57BL/6J mice the iNOS inhibitor N G -monomethyl-L-arginine (1-MA; CalBiochem) was added. 12, 13 Optimal concentrations of all reagents were determined in titration experiments. Proliferative responses were measure by adding 1 mCi of [ 3 H] thymidine (Moravek Radiochemicals, Brea, CA, USA) after 44 h of incubation. The plates were frozen 4 h after radiolabeling, then thawed for harvesting onto filter paper mats using a semi-automated cell harvester (Skatron Instruments, Richmond, VA, USA). Radioactivity was measured by liquid scintillation spectrometry. For each experiment, 3-5 wells were established for each test group.
IFN-c ELISpot
Following overnight incubation of cells plated as described above, IFN-c ELISpot assays were conducted as described by the manufacturer (eBioscience).
Statistical analysis and costimulation index (CI)
T-cell proliferative responses or number of IFN-c-secreting cells (IFNcSCs) are presented as the average c.p.m. or cell number6SEM. All data sets were compared using the Student's t-test with P values below 0.05 defined as significant. The costimulation (or cosuppression when values ,1.0) index is defined as the average costimulated (CD31CD28 stimulation) c.p.m. divided by the average control (CD3 stimulation alone) c.p.m. All results are representative of at least three or more independent experiments that generated statistically valid results each time they were conducted.
RESULTS

CD28 ligation costimulates LN but not PerC T cells
Prior research has shown that resident Mws suppress the activation of PerC T cells. 4, 13 Mw-mediated suppression in C57BL/6J PerC cell culture is blocked by the addition of the iNOS inhibitor 1-MA. Considering that resident PerC Mws are CD80 lo , CD86 lo we reasoned that T-cell costimulation was limiting and that CD28 ligation could enhance the T-cell activation evidenced in PerC cell cultures treated with 1-MA. 13 However, the opposite result was observed. While LN cell suspensions responded with an increase in T-cell proliferation to increasing concentrations of anti-CD28 (P,0.005; Figure 1a) , PerC cells exhibited a progressively diminished response (P,0.05) relative to the control (1-MA alone, no costimulation; Figure 1b) . Although a modest costimulatory response resulted from reducing the number of PerC cells cultured this did not approach that seen with LN cells (Figure 1c versus Figure 1d ; Table 1 ). Cosuppression was most evident in PerC cultures that increased Mw-T cell interaction ('U'-bottom.'V'-bottom.flat-bottom microtiter wells; Table 1 ). These results illustrate that cell culture composition and density can impact interpretation of T-cell costimulation biology.
CD28 ligation cosuppresses superantigen and CD3-independent T-cell activation The high frequency of T cells responsive to CD3 ligation invited speculation as to whether a milder form of T-cell stimulation would also be susceptible to CD28-mediated cosuppression. This was the case with the superantigen SEB, which triggered T-cell proliferation in the presence of 1-MA and was cosuppressed by CD28 ligation (Figure 1e ). Tcell activation independent of CD3 engagement was tested using the mitogenic plant lectin ConA. This response was also cosuppressed (Figure 1e ) indicating that regardless of how T cells were activated, ligation of the CD28 receptor can, under myeloid-enriched conditions, restrain T-cell proliferation.
Cosuppression is not due to Fc binding by the anti-CD28 mAb
To address the possibility that the anti-CD28 mAb triggered suppression via Fc binding, a species-and isotype-matched, nonspecific mAb was tested. Unlike the hamster anti-CD28 mAb 37.51, the hamster nonspecific control mAb failed to cosuppress T-cell proliferation ( Figure 2a ). PerC T cells from mice lacking the CD28 receptor (CD28KO) were not affected by addition of the CD28 mAb and the addition of 1-MA did not increase their proliferation (Figure 2a) . Furthermore, the CD28-binding fusion proteins B7.1-Fc and B7.2-Fc both cosuppressed the T-cell proliferative response of C57BL/6J PerC cells (Figure 2b ). These observations reinforced that the CD28 receptor can serve as a negative regulator of T-cell proliferation.
CD28 ligation cosuppresses BALB/c PerC T cells
Prior research has shown that BALB/c PerC T cells are less suppressed by resident Mw than those of C57BL/6J mice. 4 Consistent with this observation, CD28 ligation cosuppressed BALB/c PerC T cells less than C57BL/6J PerC T cells (CI50.65 versus 0.14; Figure 3 ). Regardless of the degree of cosuppression, this result illustrated that PerC T cells from two widely studied strains of mice exhibit reduced proliferative responses following CD28 ligation.
18,19
Role of IFN-c in CD28 cosuppression Since costimulation is known to increase T-cell cytokine production, we assessed whether increased production of a regulatory cytokine could be the mechanism for CD28-mediated cosuppression. 20 IL-10 and IFN-c are hallmark regulatory cytokines, so the role of these molecules was tested. The CD28-mediated cosuppression of PerC T cells from IL-10KO mice was no different than that seen for wild-type PerC cells exhibited the greatest numbers of IFN-cSCs, when a neutralizing anti-IL-10 mAb was included during their generation, particularly at high cell density (Figure 5c ). However, the greatest costimulatory increase in IFN-cSC number followed CD28 ligation of LN cells (CI57.75, Figure 6a ). This increase occurred without suppression of LN T-cell proliferation (Figure 1) . Likewise, IFN-cRKO PerC T cells, which had greater numbers of IFN-cSCs than C57BL/6J mice, were costimulated for both proliferation (Figure 4b ) and IFNcSC number (Figure 6b ). These results illustrate that while CD28 ligation increases IFN-cSC production, both the cellular composition and the cytokine milieu of the culture determine whether the T cell proliferative response will be costimulated or cosuppressed.
Role of cell surface molecules in CD28 receptor-mediated cosuppression IFN-c can increase the expression of molecules that either promote (CD40, CD80/B7.1, CD86/B7.2) or inhibit (CD274/B7H1/PDL1) T-cell activation. 21 To determine if these molecules have a role in 
T-cell cosuppression
the T-cell biology described in the preceding experiments, the PerC cells of CD40KO, B7KO and PDL1KO mice were studied. While CD40KO and PDL1KO mice exhibited cosuppression analogous to that of C57BL/6J mice (Figure 7) , the PerC T cells of B7KO mice were more similar to those of CD28KO mice (Figure 2a) in that the addition of 1-MA did not increase the T-cell proliferative response (Figure 7b) . Furthermore, B7KO PerC T cell proliferation was costimulated by CD28 ligation. Both CD28KO and B7KO mice had fewer IFN-cSCs than wild-type C57BL/6J mice ( Figure 8 ). Although costimulation significantly increased IFN-cSC number for the B7KO, the small number of these cells did not temper the proliferative response (Figure 7b ). These data reinforce that the CD28-B7 receptor-ligand pathway can trigger immune suppression via increased production of IFN-c.
CD28 receptor-mediated cosuppression requires iNOS IFN-c has been shown to inhibit T-cell proliferation by triggering Mws to increase expression of the arginine-consuming enzyme iNOS.
11,13
To assess the role of iNOS in CD28-mediated cosuppression, PerC T cells from iNOSKO mice were studied. The data show that iNOS is essential for Mw-mediated T-cell suppression and that CD28-triggered cosuppression does not occur for this strain ( 50.28) . There was only costimulation at the lowest PerC cell concentration (CIo2.03). These data reinforce that iNOS is the mechanism for cosuppression and that cognate myeloid-lymphoid interaction is an essential element of this form of T-cell regulation.
DISCUSSION
The failure of PerC T cells to proliferate in response to CD3 ligation is not an intrinsic T-cell defect nor due to APC immaturity as T-cell purification and PerC cell titration can rescue this response (Figure 1d) . 4, 13 A surplus of natural costimulation, due to increased formation of immunological synapses inherent to the APC-rich composition of PerC cells, triggered a natural 'braking system' with IFN-c production promoting iNOS expression, arginine catabolism and lymphocyte proliferative paralysis.
11,14 CD28 ligation, rather than reversing this pathway, supplemented the natural costimulatory response and increased IFN-c production and immune paralysis. This 'cosuppression' revealed the significance of the myeloid/lymphoid composition of the cellular preparation targeted for costimulation. This observation is particularly relevant to current efforts to deploy immunomodulatory drugs to amend the aberrant immune regulation that is a hallmark of myeloid-rich tumor microenvironments. 22 In vitro screening assays that can reproduce the immunosuppressive elements of tumor microenvironments will be essential to facilitate effective drug development. 
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The same anti-CD28 mAb (clone 37.51) 17 that all prior in vitro research has revealed as costimulatory has been shown to inhibit Tcell expansion and cytokine production in vivo. [29] [30] [31] Another anti-CD28 mAb (clone JJ319) 32 tempers acute graft-versus-host disease. [33] [34] [35] In these studies, CD28 blockade was thought to promote allograft tolerance by negating CD28/B7 interaction or by allowing 5 and 1.5310 5 C57BL/6J PerC cells alone or with a neutralizing anti-IL-10 mAb were cultured with anti-CD3 6anti-CD28 costimulation. All CI values represent the ratio of the costimulated response to the uncostimulated response. *P,0.05; **P,0.005. The data shown are representative of three separate experiments that generated similar results. CI, costimulation index; IFN-c-SC, interferon-c-secreting cell; mAb, monoclonal antibody; PerC, peritoneal cavity.
T-cell cosuppression
CTLA-4/B7 interaction to costimulate IFN-c production and IDO/ iNOS expression. 31, 34, 35 Since CTLA-4 ligation has been shown to restrict IFN-c production, the tolerance observed more likely reflects a cosuppressive response, a hypothesis validated by research showing that in vivo administration of the 37.51 mAb activated T cells to produce the IFN-c essential for tolerance. 31, 36 Likewise, increased numbers of IFN-cSCs and regulatory T cells (Tregs) were noted following in vivo administration of the anti-CD28 mAb E18 and a monovalent Ab (Sc28AT) promoted allograft tolerance by increasing IDO and Tregs. 37, 38 PerC Tregs are not a factor with in vitro cosuppression, because PerC cells from T cell-deficient nude and scid mice suppress exogenous T-cell proliferation via iNOS. 13 The generation of Foxp3
1
T cells is unlikely in short-term culture, particularly with IFN-c and nitric oxide suppressing their generation. 14, [39] [40] [41] [42] There is evidence, however, that IFN-c-generated regulatory APCs can promote Treg development, a factor more likely in longer term, in vivo models of T-cell tolerance. 43, 44 In vivo administration of 37.51 to BALB/c mice afforded protection from lethal septic shock via IL-10-mediated inhibition of tumor-necrosis factor-a production. 45 This observation is consistent with the T-cell cytokine biology of BALB/c (Th2/IL-10) versus (Th1/ IFN-c) C57BL/6J mice. The lower number of IFN-cSCs and less cosuppression witnessed with BALB/c PerC cells (Figures 3 and 5b) could be due to cytokine antagonism via autocrine IL-10 production by PerC B-1 B cells or Bregs. 23, 46 In support of this premise, B-1 B celldeficient BALB.xid mice have PerC IFN-cSC numbers more similar to C57BL/6J mice rather than to BALB/c mice and exhibit cosuppression responses most like C57BL/6J mice. 4 IL-10 still restrained PerC IFNcSC production in C57BL/6J mice, particularly at higher cell density (Figure 5c ). These results reinforce that culture density and cellular composition are important factors when interpreting T-cell suppression biology. Although the resolution of T cells into Th1/Th2/Th17/ Treg subsets is well established, the functional plasticity of Mws confounds their simple categorization as classically (M1) or alternatively activated (M2) cells. 11, 47, 48 There is growing appreciation for the heterogeneity of myeloid cells being a key factor in the generation of distinct T-cell subsets. 49 Direct evidence that the CD28/B7 pathway can temper immunity came with the observation that CD28KO and B7KO PerC T cells were not suppressed at culture densities that tempered C57BL/6J and PDL1KO T-cell proliferation (Figures 2 and 7) . Peripheral T-cell T-cell cosuppression D Silberman et al 346 viability depends upon the CD28/B7 pathway as both CD28KO and B7KO mice had reduced numbers of PerC CD4
1 and CD8 1 T cells relative to C57BL/6J controls. 4 PerC IFN-cSC numbers were low for both of these mutants ( Figure 8 ) and 1-MA was not required to inhibit iNOS and reveal their proliferative response (Figure 7) . Even with costimulation, B7KO PerC IFN-cSC numbers did not reach the levels seen with BALB/c mice, which were sufficient to temper T-cell proliferation. Although the greatest number of IFN-cSCs were found in IFN-cRKO mice their PerC T cells responded to anti-CD3 and were costimulated by CD28 ligation (Figure 6b ) revealing the critical role of IFN-c signaling for suppression. Although these results suggest that T cells can be expanded in Mw-rich environments, these cells may not be the IFN-c-dependent effectors required for an optimal anti-tumor response. 41, 50, 51 That PDL1KO PerC T cells were suppressed was surprising considering that PDL1 expression has been shown to restrict T-cell activation in lymphoid and normal tissue, as well as in tumors. [52] [53] [54] Since PDL1 costimulates IL-10 production the absence of this ligand likely enhanced IFN-c production and thus cosuppression (Figure 5c ). 55 In a similar fashion, fibroblastic reticular cells from PDL1KO mice were recently shown to have increased IFN-c-dependent, iNOSmediated T-cell suppression relative to wild-type control cells. 56 Although the CI was lower for PDL1KO PerC T cells relative to the C57BL/6J control (Figure 7b ), the proliferative differences were not statistically significant between these groups. Prior research has shown that neutralization of PDL1 on BALB/c Mws leads to T-cell proliferative arrest by increasing IFN-c/iNOS production; however, CD28 costimulation was not assessed in this study. 57 Although these results suggest that PDL1 is not a significant factor in IFN-c-/Mw-mediated suppression, this molecule and other B7 homologs are clearly important in other regulatory pathways. 2, 54, [58] [59] [60] [61] The complexity and variety of T cell-APC and T cell-T cell interactions among the B7 family members insure that there is more to learn regarding this important family of costimulatory/co-inhibitory molecules. 2, [59] [60] [61] In summary, depending upon the myeloid composition of the target tissue, CD28 ligation can suppress rather than costimulate T-cell proliferation. Although this pathway may be more potent than CTLA-4-Ig in controlling T-cell activation, the 'cytokine storm' that ensued following in vivo trials of a superagonist anti-CD28 mAb might have tempered enthusiasm for this strategy. 31, 62, 63 This case certainly has made it clear that additional models must be developed to assess the safety of immunomodulatory biopharmaceuticals. 
